Jiao Yang Selected Research

cucurbitacin E

4/2010	Inhibitory effect of cucurbitacin E on pancreatic cancer cells growth via STAT3 signaling.
1/2010	[Inhibitory effect of cucurbitacin E on the proliferation of ovarian cancer cells and its mechanism].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiao Yang Research Topics

Disease

64	Neoplasms (Cancer) 03/2024 - 04/2010
19	Breast Neoplasms (Breast Cancer) 04/2024 - 04/2013
17	Neoplasm Metastasis (Metastasis) 07/2023 - 04/2012
9	Pulmonary Hypertension 11/2023 - 01/2015
7	Inflammation (Inflammations) 03/2024 - 08/2015
6	Lung Neoplasms (Lung Cancer) 03/2024 - 03/2018
6	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 03/2018
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 07/2014
4	Hypoxia (Hypoxemia) 12/2023 - 01/2019
4	COVID-19 11/2023 - 12/2020
4	Glioma (Gliomas) 07/2023 - 10/2018
4	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 01/2010
4	Weight Loss (Weight Reduction) 05/2021 - 06/2016
4	Obesity 12/2020 - 04/2018
3	Genomic Instability 05/2023 - 11/2012
3	Fibrosis (Cirrhosis) 01/2022 - 06/2018
3	Carcinoma (Carcinomatosis) 01/2022 - 03/2016
3	Esophageal Neoplasms (Esophageal Cancer) 01/2020 - 01/2018
3	Stomach Neoplasms (Stomach Cancer) 10/2018 - 06/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2017 - 02/2015
2	Pain (Aches) 04/2024 - 01/2021
2	Squamous Cell Carcinoma of Head and Neck 04/2024 - 10/2017
2	Ulcerative Colitis 03/2024 - 10/2019
2	Lymphoma (Lymphomas) 01/2024 - 04/2016
2	Hemorrhage 12/2023 - 01/2022
2	Human Influenza (Influenza) 11/2023 - 01/2023
2	Pathologic Processes 09/2023 - 06/2019
2	Osteosarcoma (Osteogenic Sarcoma) 08/2023 - 12/2018
2	Diarrhea 01/2023 - 01/2016
2	Brain Neoplasms (Brain Tumor) 01/2023 - 03/2018
2	Wounds and Injuries (Trauma) 01/2023 - 01/2022
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2022 - 04/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 03/2016
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2014
2	Cognitive Dysfunction 11/2020 - 09/2015
2	Necrosis 08/2020 - 09/2014
2	Carcinogenesis 03/2020 - 01/2016
2	Heart Failure 03/2020 - 11/2014
2	Dyspnea (Shortness of Breath) 01/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 04/2024 - 03/2011
17	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2016
10	MicroRNAs (MicroRNA)IBA 11/2023 - 01/2016
6	ErbB Receptors (EGF Receptor)IBA 01/2022 - 04/2012
5	Hormones (Hormone)IBA 01/2023 - 01/2017
4	Circular RNAIBA 09/2023 - 01/2021
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 09/2019
4	Messenger RNA (mRNA)IBA 01/2022 - 07/2015
4	EnzymesIBA 01/2022 - 01/2016
4	AminesIBA 03/2019 - 05/2015
3	Trastuzumab (Herceptin)FDA Link 04/2024 - 01/2016
3	human ERBB2 proteinIBA 04/2024 - 01/2016
3	CateninsIBA 03/2024 - 01/2019
3	SmokeIBA 11/2023 - 01/2019
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 01/2017
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2016
3	Therapeutic UsesIBA 01/2022 - 02/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2013
3	Long Noncoding RNAIBA 01/2021 - 12/2018
3	CytokinesIBA 08/2020 - 02/2015
3	Thalidomide (Thalomid)FDA Link 08/2020 - 10/2016
3	Protein Kinases (Protein Kinase)IBA 03/2019 - 06/2012
3	Gefitinib (Iressa)FDA Link 03/2018 - 04/2012
3	Interleukin-2 (IL2)IBA 11/2017 - 02/2015
2	pyrotinibIBA 04/2024 - 01/2023
2	LipopolysaccharidesIBA 03/2024 - 01/2022
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 03/2024 - 01/2022
2	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2024 - 01/2016
2	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2024 - 01/2017
2	AntioxidantsIBA 01/2024 - 01/2018
2	Tobacco Smoke Pollution (Passive Smoking)IBA 11/2023 - 01/2020
2	Sulfur DioxideIBA 11/2023 - 01/2023
2	Nitrogen DioxideIBA 11/2023 - 01/2023
2	Particulate MatterIBA 11/2023 - 01/2023
2	OzoneIBA 11/2023 - 01/2023
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 07/2023
2	Peptides (Polypeptides)IBA 09/2023 - 01/2020
2	Retroelements (Retrotransposon)IBA 05/2023 - 01/2021
2	Epidermal Growth Factor (EGF)IBA 01/2023 - 10/2018
2	Estrogen ReceptorsIBA 01/2023 - 01/2019
2	VaccinesIBA 01/2023 - 11/2018
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
2	Lactic Acid (Lactate)FDA LinkGeneric 12/2022 - 01/2021
2	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2018
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 11/2014
2	Uric Acid (Urate)IBA 12/2020 - 01/2020
2	LipidsIBA 09/2020 - 11/2014
2	Indicators and Reagents (Reagents)IBA 03/2020 - 08/2017
2	C-Reactive ProteinIBA 03/2020 - 08/2015
2	Marsdeniae tenacissimae extractIBA 01/2020 - 09/2019
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020 - 03/2014
2	LigandsIBA 01/2020 - 10/2018
2	Cisplatin (Platino)FDA LinkGeneric 10/2019 - 02/2015
2	Small Interfering RNA (siRNA)IBA 09/2019 - 09/2016

Therapy/Procedure

35	Therapeutics 04/2024 - 04/2012
17	Drug Therapy (Chemotherapy) 04/2024 - 04/2010
9	Immunotherapy 01/2023 - 01/2016
3	Radiotherapy 01/2023 - 04/2013
3	Electroacupuncture 01/2022 - 02/2015
3	Neoadjuvant Therapy 01/2022 - 01/2014
3	Oral Administration 12/2014 - 04/2012